ARYA Sciences Acquisition Corp IV

ARYA Sciences Acquisition Corp IV (Nasdaq: ARYD) is a blank-check company sponsored by ARYA Sciences, the SPAC vehicle affiliated with life sciences-focused investment firm Perceptive Advisors. The company completed its initial public offering in 2021 and targets acquisition opportunities in the life sciences and biotechnology sector. As of its 10-Q filing submitted to the SEC on August 11, 2023, ARYD remained in its search phase, continuing to evaluate potential business combination candidates within its stated healthcare and biopharmaceutical focus. ARYA Sciences has launched multiple acquisition vehicles across the same sector, reflecting a serial-sponsor strategy concentrated in therapeutic development and medical innovation. Sign up for SpacDesk to access full filing history, sponsor track records, and real-time status updates on ARYD and hundreds of other active SPACs.